Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

HAVN Life Sciences Inc. (HAVLF)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
0.0397-0.0003 (-0.75%)
At close: 03:44PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close0.0400
Open0.0400
BidN/A x N/A
AskN/A x N/A
Day's Range0.0340 - 0.0420
52 Week Range0.0340 - 9.5160
Volume197,673
Avg. Volume1,344
Market Cap5.045M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.2510
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • CNW Group

    IIROC Trade Resumption - HAVN

    Trading resumes in:

  • CNW Group

    IIROC Trading Halt - HAVN

    The following issues have been halted by IIROC:

  • GlobeNewswire

    HAVN Life Announces a 30:1 Consolidation of its Common Shares

    VANCOUVER, British Columbia, July 29, 2022 (GLOBE NEWSWIRE) -- HAVN Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the "Company” or "HAVN Life") a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce that it will complete a consolidation (“Consolidation”) of its issued and outstanding common shares ‎on the basis of one (1) post-consolidation common share for every thirty (30) pre-Consolida

Advertisement
Advertisement